F-star Therapeutics Inc.

NASDAQ: FSTX · Real-Time Price · USD
7.12
0.00 (0.00%)
At close: Mar 08, 2023, 10:00 PM

F-star Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2021
Period Ending Dec 31, 2021
Net Income
-31.28M
Depreciation & Amortization
642K
Stock-Based Compensation
6.9M
Other Working Capital
-3.42M
Other Non-Cash Items
1.5M
Deferred Income Tax
-104K
Change in Working Capital
-4.92M
Operating Cash Flow
-27.27M
Capital Expenditures
-658K
Cash Acquisitions
n/a
Purchase of Investments
n/a
Sales Maturities Of Investments
n/a
Other Investing Acitivies
15K
Investing Cash Flow
-643K
Debt Repayment
n/a
Common Stock Repurchased
n/a
Dividend Paid
n/a
Other Financial Acitivies
88.1M
Financial Cash Flow
88.1M
Net Cash Flow
60.02M
Free Cash Flow
-27.93M